(The Epoch Times)—Moderna halted a clinical trial for a new vaccine because one of the participants suffered an adverse event, The Epoch Times has confirmed.
Workers at two of the trial sites said the trial for the Epstein-Barr virus vaccine, which launched in early 2022, was paused. One of the workers said the trial was halted due to an issue with one of the participants.
“We received an update about an adverse event that initiated the pause for dosing, but I, myself did not receive details on what the event was,” Maurice Beck, recruitment manager for Tekton Research, told The Epoch Times via email.
The confirmation comes after independent reporter Alex Berenson reported on an email he obtained that announced the halt.
The message, titled “all dosing must pause immediately!” informed people that the adverse event was suspected to be myocarditis, a form of heart inflammation.
“We have been informed today of an adolescent subject … that has met a pause rule of ‘possible case of myocarditis,'” the email stated. “In line with protocol guidance, this necessitates an immediate suspension of all dosing for ALL adolescent subjects.”
A Moderna investigator was said to have sent the email on Nov. 16. The Lynn Health Science Institute also confirmed to The Epoch Times that the trial was paused.
Mr. Beck said on Nov. 17 that there was no projected timeline for resuming the trial but added on Nov. 21 that the dosing pause “was lifted within a week.”
JD’s manually curated links for God-fearing MAGA patriots
UMass Chan Medical School, a third site, declined to comment, referring The Epoch Times to Moderna. The school, at the University of Massachusetts, was among the sites announcing the trial start in a press release.
“The goal is to raise robust immune responses to a broader range of proteins used by the virus for cell entry, in order to protect against infection and mononucleosis disease,” Dr. Katherine Luzuriaga, the principal investigator of the trial at UMass Chan, said at the time.
Multiple requests for comment to Moderna returned a one-away message from a spokeswoman while two other spokespeople did not respond.
The U.S. Food and Drug Administration, which regulates vaccines, declined to provide a comment by press deadline. Moderna has not publicly disclosed the halt of the phase 1 trial, which is known as Eclipse.
Companies are required to disclose to the U.S. Securities and Exchange Commission “on a rapid and current basis” information “concerning material changes in the financial condition or operations” under the Sarbanes-Oxley Act and subsequent commission rules.
The disclosures are made through form 8-K. Moderna has filed two form 8-Ks in November but did not mention the trial in either.
Dr. Andrew Bostom, a retired professor of medicine who has run clinical trials, said that Moderna is required to let study coordinators and participants know about the development.
Moderna’s COVID-19 vaccine causes myocarditis, though there’s no consensus on the mechanism by which the inflammation is caused.
Dr. Bostom told The Epoch Times in an email that the apparent case of myocarditis following Epstein-Barr vaccination raises concerns about the messenger RNA platform that Moderna uses for both the Epstein-Barr and COVID-19 vaccines.
The case “suggests the platform itself is causing inflammation, such as myocarditis, and the platform itself needs to be re-evaluated,” Dr. Bostom said. “A moratorium should be put in place until the mechanism of this potentially fatal inflammatory is better understood and eliminated.”
Epstein-Barr Vaccine Trial
Moderna announced in January 2022 that the first participant in the trial for the experimental Epstein-Barr vaccine had been dosed.
“The start of this Phase 1 study is a significant milestone as we continue to advance mRNA vaccines against latent viruses, which remain in the body for life after infection and can lead to chronic medical conditions. Moderna is committed to developing a portfolio of first-in-class vaccines against latent viruses for which there are no approved vaccines today,” Stephane Bancel, Moderna’s CEO, said at the time.
Moderna currently has no cleared products besides its COVID-19 vaccine.
The Epstein-Barr virus, named after scientists Anthony Epstein and Yvonne Barr, who discovered it, is a herpesvirus that typically spreads through saliva and other bodily fluids. It can cause illnesses such as infectious mononucleosis, which is commonly known as mono.
The virus infects many people, including about 95 percent of adults, according to the Cleveland Clinic. A number of people contract the virus during childhood. Latent viruses remain in the body after infection and can later contribute to other conditions.
The randomized, controlled trial was launched in about 15 sites in the United States. The first part was aimed at examining the safety and tolerability of the vaccine in adults aged 18 to 30 and enrolled about 270 adults.
Part B of the trial enrolled adolescents aged 12 to 17. Participants had to be in good general health, according to Moderna’s website. Participants with a history of myocarditis and/or pericarditis, a related condition, were barred from enrolling.
About 150 adolescents have been enrolled, according to the website. Participants were said to spend 18 months in the trial, with up to 15 site visits and 10 safety calls.
Bypass Big Tech Censors
Safeguarding Your American Dream: Discover the Power of America First Healthcare
In today’s economy, healthcare costs remain one of the biggest threats to financial stability and family security. Americans work hard to build a better life, yet rising medical expenses can quickly erode savings, force tough trade-offs, and even push families toward debt or bankruptcy. Medical bills continue to rank as the leading cause of personal bankruptcy in the United States, with millions facing underinsurance or unexpected out-of-pocket burdens that no one plans for. Many turn to government-run marketplace plans under the Affordable Care Act, hoping for relief, only to discover that what appears affordable on paper often delivers higher long-term costs, limited real protection, and coverage that may not align with personal values or family needs.
America First Healthcare stands out as a private insurance agency dedicated to helping conservatives and families secure better coverage and better rates through customized, values-aligned options. By conducting free insurance reviews, the agency uncovers hidden gaps in existing policies and connects clients with private alternatives that emphasize personal responsibility, small-government principles, and genuine affordability—often delivering up to 20% savings while providing stronger protection for the American Dream.
The allure of marketplace plans is easy to understand: open enrollment periods, premium tax credits for many households, and the promise of “comprehensive” benefits mandated by law. Yet recent data reveals a different reality, especially after the expiration of enhanced premium subsidies at the end of 2025. Enrollment for 2026 dropped by more than one million people compared to the prior year, with many shifting to lower-tier bronze plans to keep monthly premiums manageable.
These plans feature significantly higher deductibles—averaging around $7,500 nationally—and greater cost-sharing requirements. Families who once paid modest amounts after subsidies now face average premium increases of $65 or more per month, even as they accept plans that leave them responsible for thousands in upfront costs before meaningful coverage kicks in.
High deductibles create a dangerous barrier to care. Studies show that people in such plans are less likely to seek timely treatment for chronic conditions, attend preventive screenings, or fill necessary prescriptions. A seemingly minor illness or injury can balloon into major expenses when patients delay care until problems worsen. For a family of four, a single hospitalization, cancer diagnosis, or unexpected surgery can easily exceed the deductible, triggering coinsurance and out-of-pocket maximums that still leave substantial bills. One recent analysis noted that some proposed changes could push family deductibles toward $31,000 in future years, further exposing households to financial risk.
Beyond the numbers, marketplace plans often carry structural limitations. Coverage for certain critical services may include waiting periods or narrower networks that restrict access to preferred doctors and specialists. Preventive care is required to be covered without cost-sharing, but everything else—lab work, imaging, specialist visits, or ongoing treatment—typically waits until the deductible is met. This reactive model contrasts sharply with the proactive, holistic approach many families prefer, especially those focused on wellness, early intervention, and maintaining health to enjoy life rather than merely reacting to illness.
Values alignment represents another growing concern. Government-influenced plans operate within a framework shaped by federal mandates and political priorities that may not reflect conservative principles of limited government, personal freedom, and ethical stewardship. Families who want to direct their healthcare dollars toward providers and benefits that honor traditional values sometimes find marketplace options feel misaligned, forcing a compromise between affordability and conviction.
Private alternatives, by contrast, offer year-round flexibility without the restrictions of open enrollment windows. Independent agents can shop across a wider range of carriers to design plans tailored to specific family needs—whether that means lower deductibles for frequent medical users, broader provider networks, or add-ons that support wellness and preventive services from day one. Clients frequently report more stable premiums that do not automatically escalate each year, along with genuine cost savings once the full picture of deductibles, copays, and coverage depth is considered.
Take the experience of real families who made the switch. Amanda C. shared that her new plan felt “way better” than what she had through the marketplace. Johnny Y. noted his previous coverage kept increasing annually until he found a more stable private option. Sofia S. expressed delight with her plan and began recommending it to others. These stories echo a common theme: when families move beyond one-size-fits-all government marketplaces, they often discover customized protection that better safeguards both health and finances.
Founder Jordan Sarmiento’s own journey underscores the stakes. In 2021, a six-day hospitalization generated a $95,000 bill. Under a well-structured private “Conservative Care Coverage” plan, his out-of-pocket responsibility would have been just $500. That stark difference illustrates how thoughtful planning and private options can prevent a medical event from becoming a financial catastrophe.
Practical steps exist for anyone questioning their current coverage. Start with a no-obligation review of your existing policy to identify gaps—high deductibles, limited critical-care benefits, or escalating premiums. Compare total projected costs (premiums plus potential out-of-pocket expenses) rather than monthly premiums alone. Consider family health history, anticipated needs, and lifestyle priorities. Private agencies can present side-by-side options that include stronger wellness incentives, broader access, and plans built on shared values of self-reliance and freedom.
In an era when healthcare inflation continues to outpace general cost-of-living increases, relying solely on marketplace solutions carries growing risk. Families who proactively explore private alternatives frequently achieve meaningful savings while gaining peace of mind that their coverage truly works when needed most.
America First Healthcare makes this exploration straightforward through its free review process. Families and individuals receive personalized guidance to close coverage holes, reduce unnecessary expenses, and secure plans that align with conservative principles—protecting wallets, health, and the American Dream without government overreach. Many who complete a review discover they can enjoy better benefits for less, often saving up to 20% while gaining the customization and stability that marketplace plans struggle to deliver.
Ultimately, protecting your family’s future requires looking beyond the marketing of “affordable” government options. By understanding the long-term costs hidden in high deductibles, shifting coverage tiers, and values mismatches, Americans can make empowered choices. Private, values-driven insurance offers a smarter path—one that rewards diligence, supports wellness, and delivers real security. For those ready to move beyond the limitations of traditional marketplace plans, a simple review can reveal options designed to serve families, not bureaucracies. The American Dream thrives when individuals and families retain control over their healthcare decisions, and thoughtful private coverage plays a vital role in making that possible.